Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID-
19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April …

Abstract Background Coronaviruses such as Severe Acute Respiratory Syndrome
coronavirus (SARS), Middle Eastern Respiratory Syndrome (MERS) and Severe Acute …

Increasing data indicate that people infected with COVID-19 are at high risk for developing
long-term neurological complications, such as “brain fog” or cognitive impairment. However …

The blood–brain barrier (BBB) is a protective element of the neurovascular unit (NVU)
surrounded by astrocytes, pericytes, extracellular matrix, and the tight junctional complex …

Numerous investigations have demonstrated significant and long-lasting neurological
manifestations of COVID-19. It has been suggested that as many as four out of five patients …

Emerging evidence suggests that an important function of the sleeping brain is the removal
of wastes and toxins from the central nervous system (CNS) due to the activation of the brain …

Background The neurological effects of the coronavirus disease of 2019 (COVID-19) raise
concerns about potential long-term consequences, such as an increased risk of Alzheimer's …

Evidence suggests that patients with long COVID can experience neuropsychiatric,
neurologic, and cognitive symptoms. However, these clinical data are mostly associational …

The mechanism of Long Covid (Post-Acute Sequelae of COVID-19; PASC) is currently
unknown, with no validated diagnostics or therapeutics. SARS-CoV-2 can cause …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) caused a pandemic with
serious complications. After coronavirus disease 2019 (COVID‐19), several post‐acute …